Literature DB >> 9151364

The GABAA agonist THIP produces slow wave sleep and reduces spindling activity in NREM sleep in humans.

J Faulhaber1, A Steiger, M Lancel.   

Abstract

Recent studies in the rat demonstrated that systemic administration of muscimol and THIP, both selective GABAA receptor agonists, elevates slow wave activity in the EEG during non-rapid eye movement (NREM) sleep. In this placebo-controlled study, we assessed the influence of an oral dose of 20 mg THIP on nocturnal sleep in young healthy humans. Compared to placebo, THIP increased slow wave sleep by about 25 min. Spectral analysis of the EEG within NREM sleep revealed significant elevations in the lower frequencies (< 8 Hz) and reductions in the spindle frequency range (approximately 10-16 Hz). In accordance with previous findings in the rat, these data imply that GABAA agonists promote deep NREM sleep, without suppressing REM sleep. These effects are opposite to those induced by agonistic modulators of GABAA receptors such as benzodiazepines and are at variance with established mechanisms according to which GABAA agonists and modulatory agonists would have similar effects. The sleep response to GABAA agonists is highly similar to that evoked by sustained wakefulness, suggesting that GABAA receptors may be implicated in the homeostatic regulation of sleep.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151364     DOI: 10.1007/s002130050241

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

1.  Changes in rectal temperature and ECoG spectral power of sensorimotor cortex elicited in conscious rabbits by i.c.v. injection of GABA, GABA(A) and GABA(B) agonists and antagonists.

Authors:  Maria Frosini; Massimo Valoti; Giampietro Sgaragli
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

2.  EEG power spectra response to a 4-h phase advance and gaboxadol treatment in 822 men and women.

Authors:  Junshui Ma; Derk-Jan Dijk; Vladimir Svetnik; Yevgen Tymofyeyev; Shubhankar Ray; James K Walsh; Steve Deacon
Journal:  J Clin Sleep Med       Date:  2011-10-15       Impact factor: 4.062

3.  Sleep-stabilizing effects of E-6199, compared to zopiclone, zolpidem and THIP in mice.

Authors:  Chloé Alexandre; Alberto Dordal; Ramon Aixendri; Antonio Guzman; Michel Hamon; Joëlle Adrien
Journal:  Sleep       Date:  2008-02       Impact factor: 5.849

Review 4.  Sleep abnormalities during abstinence in alcohol-dependent patients. Aetiology and management.

Authors:  H P Landolt; J C Gillin
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Drug-related Sleep Stage Changes: Functional Significance and Clinical Relevance.

Authors:  Timothy Roehrs; Thomas Roth
Journal:  Sleep Med Clin       Date:  2010-12-01

6.  Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies.

Authors:  D Alan Lankford; Bruce C Corser; Yan-Ping Zheng; Zhengrong Li; Duane B Snavely; Christopher R Lines; Steve Deacon
Journal:  Sleep       Date:  2008-10       Impact factor: 5.849

Review 7.  [The importance of sleep for healthy alcohol consumers and alcohol dependent patients].

Authors:  H Gann; D van Calker; B Feige; D Riemann
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

Review 8.  [Significance of GABAA receptors for the pathophysiology and therapy of panic disorders].

Authors:  R Rupprecht; P Zwanzger
Journal:  Nervenarzt       Date:  2003-06-24       Impact factor: 1.214

9.  Metabolism and renal elimination of gaboxadol in humans: role of UDP-glucuronosyltransferases and transporters.

Authors:  Xiao-Yan Chu; Yuexia Liang; Xiaoxin Cai; Karla Cuevas-Licea; Ronda K Rippley; Kelem Kassahun; Magang Shou; Matthew P Braun; George A Doss; M Reza Anari; Raymond Evers
Journal:  Pharm Res       Date:  2008-12-11       Impact factor: 4.200

10.  Modafinil and sleep architecture in an inpatient-outpatient treatment study of cocaine dependence.

Authors:  Peter T Morgan; Gustavo A Angarita; Sofija Canavan; Brian Pittman; Lindsay Oberleitner; Robert T Malison; Vahid Mohsenin; Sarah Hodges; Caroline Easton; Sherry McKee; Andrew Bessette; Erica Forselius
Journal:  Drug Alcohol Depend       Date:  2016-01-08       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.